Antenatal Betamethasone for Women at Risk for Late Preterm Delivery Reduces the Rate of Neonatal Respiratory Complications

Administration of antenatal betamethasone is the standard of care for women at risk of preterm delivery; however, whether antenatal bethamethasone reduces the risk of neonatal complications in the late preterm period is unknown. This randomized controlled trial assessed the effectiveness of two doses of antenatal betamethasone in women at risk of late preterm delivery in preventing neonatal respiratory complications. The trial revealed that despite an increase in neonatal hypoglycemia among neonates whose mothers received betamethasone, the treatment effectively prevents neonatal respiratory complications.

To read more from Evidence-Based Neonatology click here.

Advertisements
This entry was posted in Uncategorized and tagged . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s